Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

R21/MM Dosing, Presentations, and Preservatives

  • Read more about R21/MM Dosing, Presentations, and Preservatives

Vagal Approaches on Long COVID-19

  • Read more about Vagal Approaches on Long COVID-19

Efficacy of Olfactive Training on Loss of Smell and Taste Caused by SARS CoV2 COVID-19 (Covid-Smell)

  • Read more about Efficacy of Olfactive Training on Loss of Smell and Taste Caused by SARS CoV2 COVID-19 (Covid-Smell)

Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer

  • Read more about Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC)

  • Read more about Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC)

Prevention of ANxiety and Depression Over Risk Assessment

  • Read more about Prevention of ANxiety and Depression Over Risk Assessment

QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer

  • Read more about QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer

Altesa BioSciences, Inc.

By jpalfreyman on Mon, 09/22/2025 - 13:55
  • Read more about Altesa BioSciences, Inc.

A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition

  • Read more about A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition

Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults

  • Read more about Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 45
  • Page 46
  • Page 47
  • Page 48
  • Current page 49
  • Page 50
  • Page 51
  • Page 52
  • Page 53
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA